Health Condition 1: null- DYSLIPIDEMIA
Conditions
Interventions
Intervention1: Patients receiving either Atorvastatin or Rosuvastatin would be enrolled: Tab. Atorvastatin 10 mg orally once daily at bedtime for three months.
Tab. Rosuvastatin 5 mg orally once daily
Sponsors
SREE MOOKAMBIKA INSTITUTE OF MEDICAL SCIENCES
Eligibility
Inclusion criteria
Inclusion criteria: 1) Hyperlipedimic patients with lipid profile: a) Total Cholesterol â?? 200 - 500 mg/dl. b) Triglycerides â?? 150-600 mg/dl. c) Low density lipoprotein â?? 100-400 mg/dl. d) High density lipoprotein - e) Very low density lipoprotein â?? 10-33 mg/dl. 2) Both sex. 3) Age : 20-60 years.
Exclusion criteria
Exclusion criteria: 1) Alcoholics. 2) Family H/O pancreatitis. 3) H/O Diabetes. 4) H/O Hypertension. 5) H/O Drug intake â?? i. Azathioprine. ii. 6-mercaptopurine. iii. Sulfonamides. iv. Estrogens. v. Tetracycline. vi. Vincristine. vii. valproic acid. viii. Steroids. ix. Anti-HIV medications. 6) H/O Pancreatic cancer. 7) H/O Renal failure. 8) H/O Endoscopic Retrograde Cholangiopancreatography. 9) Pregnancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| i. Serum lipase in Units per Liter [U/L]. ii. Blood glucose in milligram per deciliter [mg/dl]. Timepoint: THREE MONTHS | — |
Secondary
| Measure | Time frame |
|---|---|
| a) Total Cholesterol b) Triglycerides c) Low density lipoprotein d) High density lipoprotein e) Very low density lipoprotein Timepoint: THREE MONTHS | — |
Countries
India
Contacts
Public ContactPRATHAB ASIR A
SREE MOOKAMBIKA INSTITUTE OF MEDICAL SCIENCES
Outcome results
None listed